Graft Polymer (UK) PLC (GB:GPL) has released an update.
Graft Polymer (UK) PLC, a biotech firm specializing in mental health disorder therapeutics, has announced the appointment of industry veteran Dennis Purcell as its new Chairman. An interview with Purcell has been featured on Proactive Investors, highlighting the company’s mission to tackle conditions such as PTSD, which impacts millions globally. Graft Polymer’s focus is on improving treatment outcomes for these disorders, leveraging their innovative research and development strategies.
For further insights into GB:GPL stock, check out TipRanks’ Stock Analysis page.
